Insider · CIK 0001241560
Jack Bendheim
ceopresidentofficerdirectorowner
Files at PAHC (PHIBRO ANIMAL HEALTH CORP). First filing Sep 11, 2025, latest May 7, 2026.
Jack Bendheim files SEC Form 4 as CEO, president, director and 10% owner at PAHC (PHIBRO ANIMAL HEALTH CORP). Since Sep 11, 2025, Jack Bendheim has reported 0 open-market buys worth $0 and 36 open-market sells worth $32M, the latest filed on May 7, 2026.
A track record needs three past buys with six months of prices behind them; Jack Bendheim has 0, so none is measured yet.
The newest scored trade: sold $1.0M of PAHC on May 5, 2026, filed May 7, 2026, scored 35 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 33 sells worth $30M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 36
$0 bought, $32M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PAHC: PHIBRO ANIMAL HEALTH CORP
PAHCOct 9, 2026 · close 38.30
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | PHIBRO ANIMAL HEALTH CORP | $1.0M 18,608 shares | -25% | +199% from low-6% from high | |
| 35Weak | PHIBRO ANIMAL HEALTH CORP | $1.1M 21,120 shares | -22% | +199% from low-9% from high | |
| 35Weak | PHIBRO ANIMAL HEALTH CORP | $1.2M 21,120 shares | -18% | +232% from low-9% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $1.2M 21,120 shares | -55% | +262% from low-1% from high | |
| 37Weak | PHIBRO ANIMAL HEALTH CORP | $757k 14,080 shares | -27% | +227% from low-6% from high | |
| 40Moderate | PHIBRO ANIMAL HEALTH CORP | $1.2M 21,120 shares | -29% | +240% from low0% from high | |
| 35Weak | PHIBRO ANIMAL HEALTH CORP | $1.2M 22,880 shares | -24% | +222% from low-4% from high | |
| 18Weak | PHIBRO ANIMAL HEALTH CORP | $258k 5,280 shares | -5% | +203% from low-9% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $1.1M 21,120 shares | -93% | +215% from low-3% from high | |
| 36Weak | PHIBRO ANIMAL HEALTH CORP | $716k 14,080 shares | -38% | +217% from low-2% from high | |
| 36Weak | PHIBRO ANIMAL HEALTH CORP | $728k 14,080 shares | -28% | +220% from low-2% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $3.7M 72,198 shares | -59% | +216% from low-3% from high | |
| 40Moderate | PHIBRO ANIMAL HEALTH CORP | $5.4M 110,842 shares | -47% | +206% from low0% from high | |
| 34Weak | PHIBRO ANIMAL HEALTH CORP | $545k 13,180 shares | -41% | +153% from low-10% from high | |
| 34Weak | PHIBRO ANIMAL HEALTH CORP | $540k 13,465 shares | -30% | +144% from low-13% from high | |
| 12Weak | PHIBRO ANIMAL HEALTH CORP | $50k 1,235 shares | -7% | +139% from low-15% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $1.2M 27,845 shares | -63% | +157% from low-8% from high | |
| 34Weak | PHIBRO ANIMAL HEALTH CORP | $570k 14,134 shares | -37% | +147% from low-11% from high | |
| 5Weak | PHIBRO ANIMAL HEALTH CORP | $8,554 213 shares | -1% | +141% from low-14% from high | |
| 5Weak | PHIBRO ANIMAL HEALTH CORP | $13k 328 shares | -1% | +141% from low-14% from high | |
| 23Weak | PHIBRO ANIMAL HEALTH CORP | $235k 5,752 shares | -13% | +149% from low-11% from high | |
| 17Weak | PHIBRO ANIMAL HEALTH CORP | $193k 4,808 shares | -10% | +145% from low-12% from high | |
| 24Weak | PHIBRO ANIMAL HEALTH CORP | $289k 7,040 shares | -12% | +153% from low-9% from high | |
| 24Weak | PHIBRO ANIMAL HEALTH CORP | $296k 7,040 shares | -21% | +156% from low-8% from high | |
| 34Weak | PHIBRO ANIMAL HEALTH CORP | $542k 12,320 shares | -27% | +170% from low-3% from high | |
| 16Weak | PHIBRO ANIMAL HEALTH CORP | $147k 3,520 shares | -7% | +149% from low-11% from high | |
| 27Weak | PHIBRO ANIMAL HEALTH CORP | $467k 10,560 shares | -18% | +175% from low-2% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $1.4M 30,337 shares | -85% | +176% from low-1% from high | |
| 50Moderate | PHIBRO ANIMAL HEALTH CORP | $1.9M 41,823 shares | -67% | +167% from low0% from high | |
| 24Weak | PHIBRO ANIMAL HEALTH CORP | $297k 7,040 shares | -10% | +157% from low-3% from high | |
| 27Weak | PHIBRO ANIMAL HEALTH CORP | $437k 10,560 shares | -19% | +154% from low-2% from high | |
| 37Weak | PHIBRO ANIMAL HEALTH CORP | $766k 18,899 shares | -26% | +145% from low-3% from high | |
| 35Weak | PHIBRO ANIMAL HEALTH CORP | $677k 16,775 shares | -41% | +142% from low-4% from high | |
| 38Weak | PHIBRO ANIMAL HEALTH CORP | $834k 20,664 shares | -34% | +147% from low-2% from high | |
| 24Weak | PHIBRO ANIMAL HEALTH CORP | $283k 7,022 shares | -18% | +147% from low-2% from high | |
| 38Weak | PHIBRO ANIMAL HEALTH CORP | $857k 21,120 shares | -36% | +151% from low0% from high |
Transactions
The newest 50 of 147 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,264 | $55.73 | $349k | 68,496 | May 7, 2026 |
| May 5, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -776 | $56.37 | $44k | 67,720 | May 7, 2026 |
| May 6, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,634 | $57.18 | $322k | 62,086 | May 7, 2026 |
| May 6, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,406 | $58.13 | $82k | 60,680 | May 7, 2026 |
| May 7, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,350 | $47.59 | $64k | 59,330 | May 7, 2026 |
| May 7, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,149 | $48.31 | $56k | 58,181 | May 7, 2026 |
| May 7, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -2,029 | $49.19 | $100k | 56,152 | May 7, 2026 |
| Apr 28, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,652 | $55.10 | $91k | 94,228 | Apr 30, 2026 |
| Apr 28, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -4,591 | $56.06 | $257k | 89,637 | Apr 30, 2026 |
| Apr 28, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -797 | $56.69 | $45k | 88,840 | Apr 30, 2026 |
| Apr 29, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -4,002 | $52.70 | $211k | 84,838 | Apr 30, 2026 |
| Apr 29, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -3,038 | $53.21 | $162k | 81,800 | Apr 30, 2026 |
| Apr 30, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,805 | $52.65 | $306k | 75,995 | Apr 30, 2026 |
| Apr 30, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,235 | $53.32 | $66k | 74,760 | Apr 30, 2026 |
| Apr 21, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,625 | $55.35 | $90k | 115,375 | Apr 23, 2026 |
| Apr 21, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,415 | $56.17 | $304k | 109,960 | Apr 23, 2026 |
| Apr 22, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -7,040 | $54.29 | $382k | 102,920 | Apr 23, 2026 |
| Apr 23, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,619 | $54.07 | $358k | 96,301 | Apr 23, 2026 |
| Apr 23, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -421 | $54.56 | $23k | 95,880 | Apr 23, 2026 |
| Apr 14, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,548 | $59.03 | $387k | 31,572 | Apr 16, 2026 |
| Apr 14, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -492 | $59.69 | $29k | 31,080 | Apr 16, 2026 |
| Apr 15, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -2,623 | $56.27 | $148k | 28,457 | Apr 16, 2026 |
| Apr 15, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -3,618 | $57.21 | $207k | 24,839 | Apr 16, 2026 |
| Apr 15, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -799 | $58.11 | $46k | 24,040 | Apr 16, 2026 |
| Apr 16, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | CConversion Class A Common Stockindirect: See10b5-1 | +100,000 | $0.00 | $0 | 124,040 | Apr 16, 2026 |
| Apr 16, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,190 | $54.56 | $283k | 118,850 | Apr 16, 2026 |
| Apr 16, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,850 | $54.88 | $102k | 117,000 | Apr 16, 2026 |
| Apr 16, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | CConversion Class B Common Stockderivativeindirect: See10b5-1 | -100,000 | $0.00 | $0 | 19,496,034 | Apr 16, 2026 |
| Mar 30, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,423 | $53.54 | $344k | 45,777 | Mar 31, 2026 |
| Mar 30, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -617 | $54.31 | $34k | 45,160 | Mar 31, 2026 |
| Mar 31, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,609 | $53.87 | $356k | 38,551 | Mar 31, 2026 |
| Mar 31, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -431 | $54.35 | $23k | 38,120 | Mar 31, 2026 |
| Mar 24, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,523 | $52.88 | $345k | 66,797 | Mar 26, 2026 |
| Mar 24, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -517 | $53.59 | $28k | 66,280 | Mar 26, 2026 |
| Mar 25, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,572 | $55.28 | $87k | 64,708 | Mar 26, 2026 |
| Mar 25, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -4,916 | $56.00 | $275k | 59,792 | Mar 26, 2026 |
| Mar 25, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -552 | $56.86 | $31k | 59,240 | Mar 26, 2026 |
| Mar 26, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -6,760 | $56.79 | $384k | 52,480 | Mar 26, 2026 |
| Mar 26, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -280 | $57.17 | $16k | 52,200 | Mar 26, 2026 |
| Mar 17, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,280 | $51.66 | $273k | 90,920 | Mar 19, 2026 |
| Mar 18, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -4,311 | $51.80 | $223k | 86,609 | Mar 19, 2026 |
| Mar 18, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -3,598 | $53.03 | $191k | 83,011 | Mar 19, 2026 |
| Mar 18, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -2,651 | $53.64 | $142k | 80,360 | Mar 19, 2026 |
| Mar 19, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -1,939 | $51.78 | $100k | 78,421 | Mar 19, 2026 |
| Mar 19, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -4,977 | $52.79 | $263k | 73,444 | Mar 19, 2026 |
| Mar 19, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -124 | $53.24 | $6,602 | 73,320 | Mar 19, 2026 |
| Mar 12, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | CConversion Class A Common Stockindirect: See10b5-1 | +100,000 | $0.00 | $0 | 101,480 | Mar 16, 2026 |
| Mar 13, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,280 | $48.91 | $258k | 96,200 | Mar 16, 2026 |
| Mar 12, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | CConversion Class B Common Stockderivativeindirect: See10b5-1 | -100,000 | $0.00 | $0 | 19,596,034 | Mar 16, 2026 |
| Feb 24, 2026 | PAHC PHIBRO ANIMAL HEALTH CORP | SOpen-market sale Class A Common Stockindirect: See10b5-1 | -5,889 | $51.27 | $302k | 16,711 | Feb 26, 2026 |
50 of 147 rows shown.
Questions about Jack Bendheim
Answered from the filings on this page, as of the latest one.
Is Jack Bendheim buying or selling?
In the last 12 months Jack Bendheim reported 0 open-market buys worth $0 and 33 open-market sells worth $30M on SEC Form 4; the latest was sold $1.0M of PAHC on May 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Jack Bendheim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jack Bendheim has 0.
Where does Jack Bendheim file Form 4?
Jack Bendheim has filed Form 4 at PAHC (PHIBRO ANIMAL HEALTH CORP) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.